NCT00551616

Brief Summary

The purpose of this study is to assess the safety and efficacy of CDB-2914 in comparison to levonorgestrel for preventing pregnancy up to 5 days after unprotected sexual intercourse.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,221

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Apr 2007

Geographic Reach
3 countries

33 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2007

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 30, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 31, 2007

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2009

Completed
13 years until next milestone

Results Posted

Study results publicly available

March 16, 2022

Completed
Last Updated

May 3, 2022

Status Verified

April 1, 2022

Enrollment Period

2 years

First QC Date

October 30, 2007

Results QC Date

February 16, 2022

Last Update Submit

April 11, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Pregnancy

    The rate of pregnancy in women who received emergency contraception within 72 h of unprotected sexual intercourse.

    Within 72 hours of unprotected Intercourse

Secondary Outcomes (2)

  • Actual Pregnancy Rate Compared to Expected Pregnancy Rate

    Within 120 hours of unprotected Intercourse

  • Menstrual Bleeding Patterns

    within the menstrual cycle of the unprotected Intercourse

Study Arms (2)

CDB-2914

EXPERIMENTAL
Drug: CDB-2914

Levonorgestrel

ACTIVE COMPARATOR
Drug: Levonorgestrel

Interventions

Single dose

CDB-2914

Single dose

Levonorgestrel

Eligibility Criteria

Age16 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • women 16 or older in UK(except Northern Ireland) sites, 17 years or more in Northern Ireland (UK) and 18 years or more in Ireland and US
  • present within 120 hours of unprotected intercourse
  • regular menstrual cycles
  • No current use of hormonal contraception
  • Willing to not use hormonal methods of contraception until study completion
  • At least one complete menstrual cycle (2 menses) post miscarriage, delivery or abortion
  • For women who present more than 72 hours after intercourse, decline the insertion of an Intra Uterine Device for emergency contraception
  • Able to provide informed consent
  • Willing to abstain from further acts of unprotected intercourse until study completion

You may not qualify if:

  • One or more acts of unprotected intercourse more than 120 hours
  • current or recent use of hormonal methods of contraception
  • currently pregnant or breastfeeding
  • tubal ligation or current use of IUD
  • Use of hormonal emergency contraception since last menstrual period
  • Current use of IUD
  • Tubal ligation
  • Partner with a vasectomy
  • Unsure about the date of the last menstrual period
  • Severe asthma insufficiently controlled by oral glucocorticoid
  • Hypersensitivity to the active substance levonorgestrel or any of the excipients of the drug products used in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (33)

Planned Parenthood Hollywood

Los Angeles, California, United States

Location

Planned Parenthood Santa Monica

Santa Monica, California, United States

Location

Planned Parenthood of the Rocky Mountains

Boulder, Colorado, United States

Location

Planned Parenthood of the Rocky Mountains

Denver, Colorado, United States

Location

Planned Parenthood of the Rocky Mountains

Littleton, Colorado, United States

Location

Planned Parenthood of Greater Miami

Lake Worth, Florida, United States

Location

Planned Parenthood of Greater Miami

Miami, Florida, United States

Location

Planned Parenthood of Greater Miami

North Miami, Florida, United States

Location

Planned Parenthood of Greater Miami

Stuart, Florida, United States

Location

Planned Parenthood of Greater Miami

West Palm Beach, Florida, United States

Location

Planned Parenthood of Northeast Ohio Akron Health Center

Akron, Ohio, United States

Location

Planned Parenthood of Northeast Ohio Bedford Health Center

Bedford, Ohio, United States

Location

Planned Parenthood of Northeast Ohio East Cleveland Health Center

Cleveland, Ohio, United States

Location

Planned Parenthood of Northeast Ohio Old Brooklyn Health Center

Cleveland, Ohio, United States

Location

Planned Parenthood of Northeast Ohio Kent Health Center

Kent, Ohio, United States

Location

Planned Parenthood of Northeast Ohio Rocky River Health Center

Rocky River, Ohio, United States

Location

Planned Parenthood of Texas Capitol Region

Austin, Texas, United States

Location

Fannin Health Center

Houston, Texas, United States

Location

Planned Parenthood of Houston and Southeast Texas Research Department

Houston, Texas, United States

Location

Planned Parenthood Association of Utah

Ogden, Utah, United States

Location

Planned Parenthood Association of Utah

Orem, Utah, United States

Location

Planned Parenthood Association of Utah

Salt Lake City, Utah, United States

Location

Planned Parenthood Association of Utah

West Valley City, Utah, United States

Location

Well Woman Centre

Dublin, Ireland

Location

NHS Grampian Sexual and Reproductive Health

Aberdeen, United Kingdom

Location

Brook Family Planning Clinic

Belfast, United Kingdom

Location

NHS Lothian Family Planning Service

Edinburgh, United Kingdom

Location

NHS Greater Glasgow & Clyde Family Planning Service

Glasgow, United Kingdom

Location

Liverpool PCT Family Planning Services

Liverpool, United Kingdom

Location

London Sexual and Reproductive Health

London, United Kingdom

Location

Manchester Primary Care Trust

Manchester, United Kingdom

Location

Nottingham Contraception & Sexual Health Service

Nottingham, United Kingdom

Location

Oxfordshire PCT Community Health

Oxford, United Kingdom

Location

Related Publications (1)

  • Glasier AF, Cameron ST, Fine PM, Logan SJ, Casale W, Van Horn J, Sogor L, Blithe DL, Scherrer B, Mathe H, Jaspart A, Ulmann A, Gainer E. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet. 2010 Feb 13;375(9714):555-62. doi: 10.1016/S0140-6736(10)60101-8. Epub 2010 Jan 29.

MeSH Terms

Interventions

ulipristalLevonorgestrel

Intervention Hierarchy (Ancestors)

NorgestrelNorpregnenesNorpregnanesNorsteroidsSteroidsFused-Ring CompoundsPolycyclic Compounds

Results Point of Contact

Title
Henri Mathé
Organization
HRA Pharma

Study Officials

  • Anna F Glasier, MD

    NHS Lothian Family Planning Service

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 30, 2007

First Posted

October 31, 2007

Study Start

April 1, 2007

Primary Completion

April 1, 2009

Study Completion

April 1, 2009

Last Updated

May 3, 2022

Results First Posted

March 16, 2022

Record last verified: 2022-04

Locations